Clinical characteristics and prognostic implications in patients with HER2-low breast cancer undergoing neoadjuvant chemotherapy: a retrospective cohort study

被引：0
|
作者：
Zheng, Ang [1 ]
He, Junlin [2 ]
Li, Muyao [1 ]
Yao, Fan [1 ]
Jin, Feng [1 ]
Chen, Bo [1 ]
Wang, Xin [2 ]
机构：
[1] China Med Univ, Hosp 1, Shenyang, Peoples R China
[2] China Med Univ, Shenyang, Peoples R China
来源：
LANCET REGIONAL HEALTH-WESTERN PACIFIC | 2025年 / 55卷
关键词：
HER2; Low; Breast Cancer;
D O I：
10.1016/j.lanwpc.2024.101378
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [41] The impact of HER2-low status on response to neoadjuvant chemotherapy in clinically HER2-negative breast cancer
    Wei Wang
    Tingting Zhu
    Hao Chen
    Yongzhong Yao
    Clinical and Translational Oncology, 2023, 25 : 1673 - 1681
  • [42] The impact of HER2-low status on response to neoadjuvant chemotherapy in clinically HER2-negative breast cancer
    Wang, Wei
    Zhu, Tingting
    Chen, Hao
    Yao, Yongzhong
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (06): : 1673 - 1681
  • [43] Clinical Significance of HER2-low Breast Cancer
    Zaiem, Fadi
    AbuJamea, Asem
    Kheil, Mira
    Numi, Anna
    Abbas, Omar
    Awada, Sanaa
    Almsaddi, Ragad
    Al-Juburi, Saleh
    Larson, Lauren
    Jain, Deepti
    AlSaghir, Maya
    Jang, Hyejeong
    Kim, Seongho
    Bandyopadhyay, Sudeshna
    Jaiman, Sunil
    Ali-Fehmi, Rouba
    CANCER RESEARCH, 2024, 84 (09)
  • [44] Prognostic implications of HER2 change after neoadjuvant chemotherapy in HER2-positive breast cancer patients
    Sato, A.
    Maeda, Y.
    Matsumoto, A.
    Ikeda, T.
    Jinno, H.
    ANNALS OF ONCOLOGY, 2024, 35 : S1409 - S1409
  • [45] Event-free survival in HER2-low vs HER2-zero breast cancer patients submitted to neoadjuvant chemotherapy
    Sartori, Guilherme
    Ramalho, Susana
    da Silva, Leonardo Roberto
    Reinert, Tomas
    Da Rosa, Mahira Lopes
    Tavares, Grazielle Morais
    Vasconcelos, Vivian
    Mantovani, Higor
    Cabello, Ana Elisa Ribeiro Da Silva
    Coelho, Guilherme
    Mandelli, Jovana
    Zaffaroni, Facundo
    Cabello, Cesar
    Barrios, Carlos
    Graudenz, Marcia Silveira
    CANCER RESEARCH, 2024, 84 (09)
  • [46] HER2-low non-metastatic breast cancer in Qatar-a nationwide retrospective cohort study to evaluate the response to neoadjuvant chemotherapy: a real-world analysis
    Kardousha, Ahmed
    Shehada, Wafaa
    Basha, Ahmed
    Nasser, Sahar
    El Mistiri, Mufid
    Hamad, Anas
    Al-Bader, Salha Bujassoum
    Elazzazy, Shereen
    FRONTIERS IN ONCOLOGY, 2024, 14
  • [47] Improved Prognosis in HER2-Low Breast Cancer Patients with Reduced Ki67 Index After Neoadjuvant Chemotherapy: A Multi-Center Retrospective Study
    Huang, Man
    Jin, Yudi
    Wang, Mengyuan
    Song, Qiang
    Fan, Yanjia
    Zhang, Yu
    Tian, Cheng
    Zhang, Chi
    Liu, Shengchun
    BREAST CANCER-TARGETS AND THERAPY, 2024, 16
  • [48] Evolution and clinical significance of HER2-low status after neoadjuvant therapy for breast cancer
    Shang, Jiuyan
    Sun, Xuemei
    Xu, Zihang
    Cai, Lijing
    Liu, Chang
    Wu, Si
    Liu, Yueping
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [49] Characteristics, healthcare utilization, and outcomes of patients with HER2-low breast cancer
    Devon K. Check
    Bradford E. Jackson
    Katherine E. Reeder-Hayes
    Michaela A. Dinan
    Eleanor Faherty
    Jackie Kwong
    Sandhya Mehta
    Lisa Spees
    Stephanie B. Wheeler
    Lauren E. Wilson
    Clara Lam
    Breast Cancer Research and Treatment, 2024, 203 : 329 - 338
  • [50] Characteristics, healthcare utilization, and outcomes of patients with HER2-low breast cancer
    Check, Devon K.
    Jackson, Bradford E.
    Reeder-Hayes, Katherine E.
    Dinan, Michaela A.
    Faherty, Eleanor
    Kwong, Jackie
    Mehta, Sandhya
    Spees, Lisa
    Wheeler, Stephanie B.
    Wilson, Lauren E.
    Lam, Clara
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 203 (02) : 329 - 338
12345